SalvaRx Group (SALV) Sets New 1-Year Low at $10.00

Shares of SalvaRx Group Plc (LON:SALV) hit a new 52-week low on Friday . The stock traded as low as GBX 10 ($0.13) and last traded at GBX 12.50 ($0.16), with a volume of 34000 shares traded. The stock had previously closed at GBX 12.50 ($0.16).

Separately, Northland Securities reissued a “corporate” rating on shares of SalvaRx Group in a report on Tuesday, December 11th.

The firm has a market capitalization of $4.59 million and a price-to-earnings ratio of -1.79.



WARNING: This article was originally posted by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://dakotafinancialnews.com/2019/03/15/salvarx-group-salv-sets-new-1-year-low-at-10-00.html.

About SalvaRx Group (LON:SALV)

SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.

Featured Story: What is the S&P 500 Index?

Receive News & Ratings for SalvaRx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SalvaRx Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply